Unity Biotechnology Inc (UBX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

3280 BAYSHORE BOULEVARD BRISBANE, CA 94005

UNITY is developing a new class of therapeutics to slow, halt or reverse diseases of aging. UNITY's current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases.

Data as of 2021-05-08 11:57:04 -0400
Market Cap253.667 Million Shares Outstanding54.788 Million Avg 30-day Volume420.459 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-3.18 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low15.44 / 2.72 Next Earnings Date2021-05-17 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from UBX instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 3 2 50.0% 1 (0.06%) 1 (0.06%) 0.0%
Funds Holding: 85 79 7.59% 19 (1.14%) 20 (1.24%) -5.0%
13F shares: 20.899 Million 19.689 Million 6.15% 3.009 Million 2.68 Million 12.29%
% Ownership 39.4971 37.2103 6.15% 5.6866 5.0644 12.29%
New Positions: 19 19 0.0% 9 8 12.5%
Increased Positions 35 22 59.09% 7 2 250.0%
Closed Positions 13 23 -43.48% 10 12 -16.67%
Reduced Positions 12 22 -45.45% 9
Total Calls 126.053 Thousand 138.48 Thousand -8.97% 65.6 Thousand 57 Thousand 15.09%
Total Puts 90.034 Thousand 203.747 Thousand -55.81% 62.9 Thousand 79.2 Thousand -20.58%
PUT/CALL Ratio 0.71 1.47 -51.7% 0.96 1.39 -30.94%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding UBX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding UBX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DANANBERG JAMIE CHIEF MEDICAL OFFICER

  • Officer
689,390 2021-03-30 3

NGUYEN ALEXANDER HIEU SEE REMARKS

  • Officer
250,000 2021-03-09 2

DAVID NATHANIEL E

  • Director
0 2021-01-29 4

GHOSH ANIRVAN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
850,000 2021-01-29 2

LEONARD KEITH R

  • Director
390,536 2020-12-31 3

O'NEILL GILMORE NEIL

  • Director
0 2020-12-10 2

SULLIVAN LYNNE MARIE CHIEF FINANCIAL OFFICER

  • Officer
240,000 2020-09-13 3

AZOY ALEXANDER SEE REMARKS

  • Officer
135,000 2020-09-13 2

MARQUESS DAN CHIEF SCIENTIFIC OFFICER

  • Officer
380,690 2020-06-22 1

GOELTZ II ROBERT C. CHIEF FINANCIAL OFFICER

  • Officer
161,027 2020-06-22 1

TOMPKINS TAMARA SEE REMARKS

  • Officer
42,847 2020-06-22 1

LACEY DAVID L.

  • Director
0 2020-06-18 1

COOPER GRAHAM K

  • Director
0 2020-06-18 1

BERNS PAUL L

  • Director
0 2020-06-18 1

NELSEN ROBERT

  • Director
0 2020-06-18 1

SAMUELS CAMILLE D

  • Director
0 2020-06-18 1

BUROW KRISTINA

  • Director
0 2020-06-18 1

ROBERTS MARGO R

  • Director
0 2020-06-18 1

ARCH VENTURE PARTNERS VII, LLC

ARCH VENTURE PARTNERS VII, L.P.

ARCH VENTURE FUND VII, L.P.

ARCH VENTURE PARTNERS VIII, LLC

ARCH VENTURE FUND VIII OVERAGE, L.P.

CRANDELL KEITH

BYBEE CLINTON

  • 10% Owner
10,048,181 2018-05-07 0

ARCH VENTURE PARTNERS VII, LLC

ARCH VENTURE PARTNERS VII, L.P.

ARCH VENTURE FUND VII LP

ARCH VENTURE PARTNERS VIII, LLC

ARCH VENTURE FUND VIII OVERAGE, L.P.

NELSEN ROBERT

CRANDELL KEITH

BYBEE CLINTON

  • Director
  • 10% Owner
39,547 2018-05-02 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

DANANBERG JAMIE - Officer CHIEF MEDICAL OFFICER

2021-04-01 17:13:19 -0400 2021-03-30 F 2,829 $5.73 d 689,390 direct -2.5848 -9.5315 0.0 1 -9.5315 6

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
UNITY BIOTECHNOLOGY INC UBX 2021-05-10 22:15:04 UTC -0.4682 0.5182 150000
UNITY BIOTECHNOLOGY INC UBX 2021-05-10 21:45:02 UTC -0.4682 0.5182 150000
UNITY BIOTECHNOLOGY INC UBX 2021-05-10 21:15:02 UTC -0.4682 0.5182 150000
UNITY BIOTECHNOLOGY INC UBX 2021-05-10 20:45:03 UTC -0.4682 0.5182 150000
UNITY BIOTECHNOLOGY INC UBX 2021-05-10 20:15:03 UTC -0.4682 0.5182 150000
UNITY BIOTECHNOLOGY INC UBX 2021-05-10 19:45:03 UTC -0.4682 0.5182 150000
UNITY BIOTECHNOLOGY INC UBX 2021-05-10 19:15:03 UTC -0.4682 0.5182 150000
UNITY BIOTECHNOLOGY INC UBX 2021-05-10 18:45:03 UTC -0.4675 0.5175 150000
UNITY BIOTECHNOLOGY INC UBX 2021-05-10 18:15:03 UTC -0.4675 0.5175 150000
UNITY BIOTECHNOLOGY INC UBX 2021-05-10 17:45:02 UTC -0.4675 0.5175 400000
UNITY BIOTECHNOLOGY INC UBX 2021-05-10 17:15:03 UTC -0.4675 0.5175 400000
UNITY BIOTECHNOLOGY INC UBX 2021-05-10 16:45:03 UTC -0.4676 0.5176 400000
UNITY BIOTECHNOLOGY INC UBX 2021-05-10 16:15:03 UTC -0.4676 0.5176 400000
UNITY BIOTECHNOLOGY INC UBX 2021-05-10 15:45:03 UTC -0.4676 0.5176 300000
UNITY BIOTECHNOLOGY INC UBX 2021-05-10 15:15:03 UTC -0.4676 0.5176 300000
UNITY BIOTECHNOLOGY INC UBX 2021-05-10 14:45:04 UTC -0.4697 0.5197 300000
UNITY BIOTECHNOLOGY INC UBX 2021-05-10 14:15:04 UTC -0.4697 0.5197 300000
UNITY BIOTECHNOLOGY INC UBX 2021-05-10 13:45:04 UTC -0.4697 0.5197 300000
UNITY BIOTECHNOLOGY INC UBX 2021-05-10 13:15:03 UTC -0.4697 0.5197 300000
UNITY BIOTECHNOLOGY INC UBX 2021-05-10 12:45:02 UTC -0.4697 0.5197 300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments